Alliance Pharmaceutical Corp. announces public offering.SAN DIEGO--(BUSINESS WIRE)--April 2, 1996--Alliance Pharmaceutical Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ALLP ALLP Aldo Leopold Leadership Program ) Tuesday announced that its public offering of 2,500,000 shares of common stock has been declared effective. The shares have been offered at a price of $16.50 per share by Lehman Brothers, Cowen & Co. and Oppenheimer & Co. Inc., the managing underwriters for the offering. Alliance is a pharmaceutical research and development company focusing on transforming scientific discoveries into potential drug products. The company has three products in clinical trials: LiquiVent, an intrapulmonary agent for treatment of acute respiratory failure, being developed by Alliance and Hoechst Marion Roussel Inc.; Oxygent, an intravascular intravascular /in·tra·vas·cu·lar/ (in?trah-vas´ku-lar) within a vessel. in·tra·vas·cu·lar adj. Within one or more blood vessels. oxygen carrier for use as a temporary "blood substitute" to reduce or eliminate the requirement for allogeneic allogeneic /al·lo·ge·ne·ic/ (-je-ne´ik) 1. having cell types that are antigenically distinct. 2. in transplantation biology, denoting individuals (or tissues) that are of the same species but antigenically (donor) blood transfusions during elective surgery, being developed by Alliance and affiliates of Johnson & Johnson; and Imagent US, a perfluorochemical-based intravenous ultrasound contrast agent being developed to aid in the assessment of cardiac function and myocardial myocardial /myo·car·di·al/ (-kahr´de-al) pertaining to the muscular tissue of the heart. myocardial pertaining to the muscular tissue of the heart (the myocardium). perfusion, as well as the detection of solid organ esions and blood flow abnormalities. CONTACT: Alliance Pharmaceutical Corp., San Diego Gwen Rosenberg, 619/558-4300 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion